Publications

5891 Results

Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from the intergroup trial CALBG 89803 [PMID22147942; PMC3271172]; https://www.ncbi.nlm.nih.gov/pubmed/22147942

Authors
S Ogino;K Shima;J Meyerhardt;NJ McCleary;K Ng;L Saltz;R Mayer;P Schaefer;R Whittom;A Hantel;A Benson;D Spiegelman;R Goldberg;M Bertagnolli;C Fuchs
Journal / Conference
Clinical Cancer Research 18(3):890-900
Year
2012
Research Committee(s)
Gastrointestinal
Study Number(s)
C89803

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

Authors
R Peto;C Davies;J Godwin;R Gray;H Pan;M Clarke;D Cutter;S Darby;P McGale;C Taylor;YC Yang;J Bergh;A DiLeo;K Albain;S Swain;M Piccart;K Pritchard
Journal / Conference
Lancet 379(9814):432-444
Year
2012
Research Committee(s)
Breast
PMID
PMID22152853
PMC
PMC3273723
Study Number(s)
SWOG-8814

When progressive disease does not mean treatment failure: reconsidering the criteria for progression

Authors
G Oxnard;M Morris;S Hodi;L Baker;A Venook;L Schwartz
Journal / Conference
Journal of the National Cancer Institute 104(20):1534-1541;
Year
2012
Research Committee(s)
Multiple sites
PMID
PMID22927506
PMC
PMC3708548

Initial cooperative group experience of bevacizumab (BEV) plus concomitant chemoradiotherapy (CRT) in patients with inoperable locally advanced stage III non-small cell lung cancer (LA-NSCLC): preliminary results of S0533

Authors
CR Thomas;J Moon;L Gaspar;D Raben;TJ Fitzgerald;A Wozniak;K Kelly;P Mack;KJ Pandya;DR Gandara
Journal / Conference
International Journal of Radiation Oncology, Biology & Physics 84(3):suppl., p S156; ASTRO 2012 Annual Meeting, oral;
Year
2012
Research Committee(s)
Lung
Study Number(s)
S0533

A phase II trial of R-CHOP plus bevacizumab for patients with newly diagnosed diffuse large b-cell non-hodgkin lymphoma: SWOG 0515

Authors
A Stopeck;JM Unger;L Rimsza;M LeBlanc;B Farnsworth;M Iannone;M Glenn;RI Fisher;TP Miller
Journal / Conference
Blood 120(6):1210-1217
Year
2012
Research Committee(s)
Lymphoma
PMID
PMID22734071
PMC
PMC3418716
Study Number(s)
S0515

The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007)

Authors
W Wong;SD Ramsey;W Barlow;LP Garrison;DL Veenstra
Journal / Conference
Contemporary Clinical Trials 33(6):1117-1123;
Year
2012
Research Committee(s)
Breast
PMID
PMID2298189
PMC
PMC3486702
Study Number(s)
S1007

Intermittent androgen suppression for rising PSA levels after radiotherapy

Authors
J Crook;CJ O'Callaghan;G Duncan;DP Dearnaley;CS Higano;EM Horwitz;E Frymire;S Malone;J Chin;A Nabid;P Warde;T Corbett;S Angyalfi;SL Goldenberg;MK Gospodarowicz;F Saad;JP Logue;E Hall;PF Schellhammer;K Ding;L Klotz
Journal / Conference
New England Journal of Medicine 367(10):895-903
Year
2012
Research Committee(s)
Genitourinary
PMID
PMID22931259
PMC
PMC3521033
Study Number(s)
JPR7

Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomized trial

Authors
AH Paterson;SJ Anderson;BC Lembersky;L Fehrenbacher;CL Falkson;KM King;LM Weir;AM Brufsky;S Dakhil;T Lad;L Baez-Diaz;J Gralow;A Robidoux;EA Perez;Ping Zheng;CE Geyer;SM Swain;JP Costantino;EP Mamounas;N Wolmark
Journal / Conference
Lancet Oncology 13(7):734-742
Year
2012
Research Committee(s)
Breast
PMID
PMID22704583
PMC
PMC4970583

Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512

Authors
S Bhatia;J Moon;K Margolin;J Weber;C Lao;M Othus;A Aparicio;A Ribas;V Sondak
Journal / Conference
PLoS ONE 7(11):e48787;
Year
2012
Research Committee(s)
Melanoma
PMID
PMID23226204
PMC
PMC3511501
Study Number(s)
S0512

Circulating tumor cell (CTC) counts and CTC telomerase activity (TA) are prognostic of overall survival (OS) in SWOG S0421 - docetaxel with or without atrasentan for metastatic castration resistant prostate cancer (mCRPC)

Authors
A Goldkorn;N Vogelzang;B Ely;LM Fink;DI Quinn;C Tangen;Y-C Tai;P Twardowski;PJ Van Veldhuizen;N Agarwal;MA Carducci;JP Monk;M Garzotto;P Mack;P Lara;C Higano;C Higano;R Cote;IM Thompson
Journal / Conference
Journal of Clinical Oncology 30:(suppl 30; abstr 1); ASCO Markers in Cancer Annual Mtg, accepted, oral (Oct 11-13, 2012 Hollywood, FL);
Year
2012
Research Committee(s)
Genitourinary
Study Number(s)
S0421